RESUMEN
Iodothyronine deiodinases (Dios) are important selenoproteins that control the concentration of the active thyroid hormone (TH) triiodothyronine through regioselective deiodination. The X-ray structure of a truncated monomer of Type III Dio (Dio3), which deiodinates TH inner rings through a selenocysteine (Sec) residue, revealed a thioredoxin-fold catalytic domain supplemented with an unstructured Ω-loop. Loop dynamics are driven by interactions of the conserved Trp207 with solvent in multi-microsecond molecular dynamics simulations of the Dio3 thioredoxin(Trx)-fold domain. Hydrogen bonding interactions of Glu200 with residues conserved across the Dio family anchor the loop's N-terminus to the active site Ser-Cys-Thr-Sec sequence. A key long-lived loop conformation coincides with the opening of a cryptic pocket that accommodates thyroxine (T4) through an Iâ¯Se halogen bond to Sec170 and the amino acid group with a polar cleft. The Dio3-T4 complex is stabilized by an Iâ¯O halogen bond between an outer ring iodine and Asp211, consistent with Dio3 selectivity for inner ring deiodination. Non-conservation of residues, such as Asp211, in other Dio types in the flexible portion of the loop sequence suggests a mechanism for regioselectivity through Dio type-specific loop conformations. Cys168 is proposed to attack the selenenyl iodide intermediate to regenerate Dio3 based upon structural comparison with related Trx-fold proteins.
Asunto(s)
Química Computacional/métodos , Yoduro Peroxidasa/metabolismo , Tiroxina/química , Tiroxina/metabolismo , Halógenos/química , Enlace de Hidrógeno , Yoduro Peroxidasa/química , Yoduro Peroxidasa/fisiología , Conformación Molecular , Selenocisteína , Selenoproteínas/metabolismo , Selenoproteínas/fisiología , Transducción de Señal , Hormonas Tiroideas , Triyodotironina/metabolismoRESUMEN
Background: Inflammation is associated with marked changes in cellular thyroid hormone (TH) metabolism in triiodothyronine (T3) target organs. In the hypothalamus, type 2 deiodinase (D2), the main T3 producing enzyme, increases upon inflammation, leading to an increase in local T3 availability, which in turn decreases thyrotropin releasing hormone expression in the paraventricular nucleus. Type 3 deiodinase (D3), the T3 inactivating enzyme, decreases during inflammation, which might also contribute to the increased T3 availability in the hypothalamus. While it is known that D2 is regulated by nuclear factor κB (NF-κB) during inflammation, the underlying mechanisms of D3 regulation are unknown. Therefore, the aim of the present study was to investigate inflammation-induced D3 regulation using in vivo and in vitro models. Methods: Mice were injected with a sublethal dose of bacterial endotoxin (lipopolysaccharide [LPS]) to induce a systemic acute-phase response. A human neuroblastoma (SK-N-AS) cell line was used to test the involvement of the thyroid hormone receptor alpha 1 (TRα1) as well as the activator protein-1 (AP-1) and NF-κB inflammatory pathways in the inflammation-induced decrease of D3. Results: D3 expression in the hypothalamus was decreased 24 hours after LPS injection in mice. This decrease was similar in mice lacking the TRα. Incubation of SK-N-AS cells with LPS robustly decreased both D3 mRNA expression and activity. This led to increased intracellular T3 concentrations. The D3 decrease was prevented when NF-κB or AP-1 was inhibited. TRα1 mRNA expression decreased in SK-N-AS cells incubated with LPS, but knockdown of the TRα in SK-N-AS cells did not prevent the LPS-induced D3 decrease. Conclusions: We conclude that the inflammation-induced D3 decrease in the hypothalamus is mediated by the inflammatory pathways NF-κB and AP-1, but not TRα1. Furthermore, the observed decrease modulates intracellular T3 concentrations. Our results suggest a concerted action of inflammatory modulators to regulate both hypothalamic D2 and D3 activities to increase the local TH concentrations.
Asunto(s)
Hipotálamo/enzimología , Inflamación/metabolismo , Yoduro Peroxidasa/genética , Animales , Línea Celular Tumoral , Regulación hacia Abajo , Femenino , Humanos , Yoduro Peroxidasa/fisiología , Lipopolisacáridos , Masculino , Ratones , FN-kappa B/fisiología , ARN Mensajero/análisis , Transducción de Señal , Receptores alfa de Hormona Tiroidea/fisiología , Factor de Transcripción AP-1/fisiología , Yodotironina Deyodinasa Tipo IIRESUMEN
Seasonal rhythms in physiology are widespread among mammals living in temperate zones. These rhythms rely on the external photoperiodic signal being entrained to the seasons, although they persist under constant conditions, revealing their endogenous origin. Internal long-term timing (circannual cycles) can be revealed in the laboratory as photoperiodic history-dependent responses, comprising the ability to respond differently to similar photoperiodic cues based on prior photoperiodic experience. In juveniles, history-dependence relies on the photoperiod transmitted by the mother to the fetus in utero, a phenomenon known as "maternal photoperiodic programming" (MPP). The response to photoperiod in mammals involves the nocturnal pineal hormone melatonin, which regulates a neuroendocrine network including thyrotrophin in the pars tuberalis and deiodinases in tanycytes, resulting in changes in thyroid hormone in the mediobasal hypothalamus. This review addresses MPP and discusses the latest findings on its impact on the thyrotrophin/deiodinase network. Finally, commonalities between MPP and other instances of endogenous seasonal timing are considered, and a unifying scheme is suggested in which timing arises from a long-term communication between the pars tuberalis and the hypothalamus and resultant spontaneous changes in local thyroid hormone status, independently of the pineal melatonin signal.
Asunto(s)
Células Ependimogliales/fisiología , Hipotálamo/fisiología , Yoduro Peroxidasa/fisiología , Intercambio Materno-Fetal/fisiología , Fotoperiodo , Reproducción/fisiología , Hormonas Tiroideas/fisiología , Animales , Femenino , Melatonina/fisiología , Sistemas Neurosecretores/fisiología , Periodicidad , EmbarazoRESUMEN
In seasonal rodents, reproduction is activated by a long photoperiod. Furthermore, maintaining an inhibitory short photoperiod for over 20 weeks triggers a spontaneous reactivation of the gonadotropic axis called photorefractoriness. Photoactivation is proposed to involve melatonin, hypothalamic thyroid hormones (TH) and (Arg) (Phe)-amide peptides. The mechanisms involved in photorefractoriness are so far unknown. We analyzed the dynamic changes in long photoperiod- and photorefractory-induced activation of reproduction in both Syrian and Djungarian hamsters to validate the current model of photoactivation and to uncover the mechanisms involved in photorefractoriness. We detected a conserved early inhibition of expression of the TH catabolizing enzyme deiodinase 3 (Dio3) in tanycytes, associated with a late decrease of the TH transporter MCT8. This suggests that an early peak of hypothalamic TH may be involved in both photoinduced and photorefractory reactivation. In photoactivation, Dio3 downregulation is followed by an upregulation of Dio2, which is not observed in photorefraction. The upregulation of (Arg) (Phe)-amides occurs several weeks after the initial Dio3 inhibition. In conclusion, we uncovered a so far unreported early inhibition of Dio3. This early downregulation of Dio3 is reinforced by an upregulation of Dio2 in photoactivated hamsters. In photorefractoriness, the Dio3 downregulation might be sufficient to reactivate the gonadotropic axis.
Asunto(s)
Ritmo Circadiano/efectos de los fármacos , Yoduro Peroxidasa/fisiología , Reproducción/fisiología , Animales , Cricetinae , Regulación hacia Abajo , Gonadotrofos/metabolismo , Gonadotropinas/metabolismo , Hipotálamo/metabolismo , Yoduro Peroxidasa/metabolismo , Masculino , Melatonina/farmacología , Proteínas de Transporte de Membrana/metabolismo , Mesocricetus , Phodopus , Fotoperiodo , Estaciones del Año , Glándula Tiroides/metabolismo , Hormonas Tiroideas/metabolismoRESUMEN
PURPOSE OF REVIEW: To provide information on the role of the essential trace element selenium, which enables appropriate thyroid hormone synthesis, secretion, and metabolism, and to discuss supplementation with various selenium compounds, which prevent thyroid diseases such as goiter and exert beneficial effects in thyroid autoimmune diseases. RECENT FINDINGS: Selenium administration in both autoimmune thyroiditis (M. Hashimoto) and mild Graves' disease improves clinical scores and well-being of patients and reduces autoimmune antibody titres in several prospective, placebo-controlled supplementation studies. SUMMARY: Adequate nutritional supply of selenium, together with the two other essential trace elements iodine and iron, is required for a healthy thyroid during development and adolescence, as well as in the adult and aging populations.
Asunto(s)
Selenio/fisiología , Glándula Tiroides/fisiología , Adulto , Animales , Hipotiroidismo Congénito/etiología , Humanos , Yoduro Peroxidasa/fisiología , Mixedema/etiología , Estrés Oxidativo/fisiología , Selenoproteínas/fisiologíaRESUMEN
Perihypothalamic thyroid hormone signaling features prominently in the seasonal control of reproductive physiology. Triiodothyronine (T(3)) signaling stimulates gonadal development, and decrements in T(3) signaling are associated with gonadal regression. Type 3 iodothyronine deiodinase (DIO3) converts the prohormone thyroxine (T(4)) into biologically inactive 3,3',5'-triiodothyronine, and in long-day breeding Siberian hamsters exposure to long (LD) and short (SD) photoperiods, respectively, inhibit and stimulate hypothalamic dio3 mRNA expression. Reproductive responses to intermediate-duration photoperiods (IntD) occur in a history-dependent manner; IntDs are interpreted as inhibitory only when preceded by longer photoperiods. Because dio3 expression has only been evaluated under LD or SD photoperiods, it is not known whether hypothalamic dio3 encodes absolute photoperiod duration or the reproductive interpretation of photoperiod. Male Siberian hamsters with and without a prior history of LD were exposed to IntD photoperiods, and hypothalamic dio3 mRNA expression was measured 6 wk later. Hamsters with a LD photoperiod history exhibited gonadal regression in IntD and a marked upregulation of hypothalamic dio3 expression, whereas in hamsters without prior exposure to LD, gonadal responses to IntD were absent, and dio3 expression remained low. Patterns of deiodinase expression in hamsters maintained in chronic IntD photoperiods did not appear to reflect feedback effects of gonadal status. Hypothalamic expression of dio3 does not exclusively reflect ambient photoperiod, but rather the context-dependent reproductive interpretation of photoperiod. Neuroendocrine mechanisms that compare current and prior photoperiods, which permit detection of directional changes in day length, occur either upstream, or at the level, of hypothalamic dio3 expression.
Asunto(s)
Hipotálamo/enzimología , Hipotálamo/fisiología , Yoduro Peroxidasa/biosíntesis , Fotoperiodo , ARN Mensajero/biosíntesis , Animales , Cricetinae , Femenino , Regulación Enzimológica de la Expresión Génica/genética , Regulación Enzimológica de la Expresión Génica/fisiología , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/fisiología , Masculino , Melatonina/fisiología , Actividad Motora/fisiología , Tamaño de los Órganos/fisiología , Phodopus , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducción/fisiología , Estaciones del Año , Vesículas Seminales/crecimiento & desarrollo , Vesículas Seminales/fisiología , Testículo/crecimiento & desarrollo , Testículo/fisiologíaRESUMEN
The levels of the serum thyroid hormone (free T4 and free T3) are determined not only by thyroid hormone synthesis/secretion but also by their metabolism. Thyroid hormone metabolism is mediated by three selenoproteins, selenodeiodinase type 1, 2, and 3 (D1, D2, and D3), the expression and function of which are tightly regulated in a tissue-specific manner. Among them, D2 increases and D3 decreases the intracellular thyroid hormone levels, whereas D1 seems to play a role as a housekeeping/scavenger enzyme in general thyroid hormone metabolism. Although no mutation in either of the deiodinase enzyme genes has been reported, some related genes (SECISBP2, DEHAL1, and MCT8) can cause thyroid hormone-related inherited disorders. In addition, a variety of hormones, cytokines, and drugs can influence thyroid function through altered thyroid hormone metabolism.
Asunto(s)
Enfermedades de la Tiroides , Hormonas Tiroideas/metabolismo , Humanos , Hidrolasas/fisiología , Inflamación/complicaciones , Yoduro Peroxidasa/fisiología , Proteínas de la Membrana/fisiología , Transportadores de Ácidos Monocarboxílicos/genética , Transportadores de Ácidos Monocarboxílicos/fisiología , Mutación , Neoplasias , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/fisiología , Selenio/deficiencia , Selenoproteínas/fisiología , Simportadores , Enfermedades de la Tiroides/etiología , Enfermedades de la Tiroides/metabolismo , Hormonas Tiroideas/sangreAsunto(s)
Fotoperiodo , Estaciones del Año , Tirotropina/fisiología , Vertebrados/fisiología , Animales , Hipotálamo/fisiología , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/fisiología , Melatonina/fisiología , Hipófisis/fisiología , Reproducción/genética , Reproducción/fisiología , Transducción de Señal , Yodotironina Deyodinasa Tipo IIRESUMEN
Tanycytes comprise a heterogeneous population of specialized cells of glial origin that line the floor and ventrolateral walls of the third ventricle between the rostral and caudal limits of the hypothalamic median eminence. While morphologic and ultrastructural features suggest a role as barrier cells, creating separate compartments between the cerebrospinal fluid, median eminence and hypothalamus, tanycytes likely have multiple other important functions that have yet to be fully elucidated. Possibilities to consider are a role in neuroendocrine regulation including modulation of the hypothalamic-pituitary-thyroid axis during fasting and infection, regulation of reproductive function, particularly in seasonal breeders, and in feeding.
Asunto(s)
Epéndimo/citología , Gónadas/fisiología , Hipotálamo/fisiología , Neuroglía/fisiología , Adenohipófisis/fisiología , Tercer Ventrículo/citología , Glándula Tiroides/fisiología , Animales , Axones/ultraestructura , Transporte Biológico/fisiología , Barrera Hematoencefálica , Citocinesis , Ayuno/fisiología , Humanos , Infecciones/fisiopatología , Yoduro Peroxidasa/fisiología , Lipopolisacáridos/farmacología , Regeneración Nerviosa/fisiología , Neuroglía/clasificación , Neuroglía/efectos de los fármacos , Neuroglía/enzimología , Periodicidad , Reproducción/fisiología , Yodotironina Deyodinasa Tipo IIRESUMEN
Iodothyronine deiodinases (D1, D2, and D3) comprise a family of selenoproteins that are involved in the conversion of thyroxine (T(4)) to active triiodothyronine (T(3)), and also the inactivation of both thyroid hormones. The deiodinase enzymes are of critical importance for the normal development and function of the central nervous system. D1 is absent from the human brain, suggesting that D2 and D3 are the two main enzymes involved in the maintenance of thyroid hormone homeostasis in the central nervous system, D2 as the primary T(3)-producing enzyme, and D3 as the primary inactivating enzyme. While the coordinated action of D2 and D3 maintain constant T(3) levels in the cortex independently from the circulating thyroid hormone levels, the role of deiodinases in the hypothalamus may be more complex, as suggested by the regulation of D2 activity in the hypothalamus by infection, fasting and changes in photoperiod. Tanycytes, the primary source of D2 activity in the hypothalamus, integrate hormonal and probably neuronal signals, and under specific conditions, may influence neuroendocrine functions by altering local T(3) tissue concentrations. This function may be of particular importance in the regulation of the hypothalamic-pituitary-thyroid axis during fasting and infection, and in the regulation of appetite and reproductive function. Transient expression of D3 in the preoptic region during a critical time of development suggests a special role for this deiodinase in sexual differentiation of the brain.
Asunto(s)
Regulación del Desarrollo de la Expresión Génica , Hipotálamo/embriología , Hipotálamo/patología , Yoduro Peroxidasa/fisiología , Hormonas Tiroideas/metabolismo , Animales , Apetito , Encéfalo/enzimología , Caquexia/patología , Ayuno , Humanos , Hipotálamo/enzimología , Hipotiroidismo , Infecciones , Yoduro Peroxidasa/metabolismo , Luz , Modelos Biológicos , Neuronas/metabolismo , Sistemas Neurosecretores , ARN Mensajero/metabolismo , Ratas , Diferenciación Sexual , Enfermedades de la Tiroides/patología , Distribución Tisular , Triyodotironina/metabolismoRESUMEN
Types 1 and 3 iodothyronine deiodinases are known to be selenocysteine-containing enzymes. Although a putative human type 2 iodothyronine deiodinase (D2) gene (hDio2) encoding a similar selenoprotein has been identified, basal D2 activity is not selenium (Se)-dependent nor has D2 been labeled with (75)Se. A human mesothelioma cell line (MSTO-211H) has recently been shown to have approximately 40-fold higher levels of hDio2 mRNA than mesothelial cells. Mesothelioma cell lysates activate thyroxine (T(4)) to 3,5,3'-triiodothyronine with typical characteristics of D2 such as low K(m) (T(4)), 1.3 nm, resistance to propylthiouracil, and a short half-life ( approximately 30 min). D2 activity is approximately 30-fold higher in Se-supplemented than in Se-depleted medium. An antiserum prepared against a peptide deduced from the Dio2 mRNA sequence precipitates a (75)Se protein of the predicted 31-kDa size from (75)Se-labeled mesothelioma cells. Bromoadenosine 3'5' cyclic monophosphate increases D2 activity and (75)Se-p31 approximately 2.5-fold whereas substrate (T(4)) reduces both D2 activity and (75)Se-p31 approximately 2-3-fold. MG132 or lactacystin (10 microm), inhibitors of the proteasome pathway by which D2 is degraded, increase both D2 activity and (75)Se-p31 3-4-fold and prevent the loss of D2 activity during cycloheximide or substrate (T(4)) exposure. Immunocytochemical studies with affinity-purified anti-hD2 antibody show a Se-dependent increase in immunofluorescence. Thus, human D2 is encoded by hDio2 and is a member of the selenodeiodinase family accounting for its highly catalytic efficiency in T(4) activation.
Asunto(s)
Acetilcisteína/análogos & derivados , Yoduro Peroxidasa/biosíntesis , Yoduro Peroxidasa/fisiología , Mesotelioma/enzimología , Proteínas/química , Acetilcisteína/farmacología , Animales , Humanos , Inmunohistoquímica , Yoduro Peroxidasa/química , Cinética , Microscopía Confocal , Microscopía Fluorescente , Propiltiouracilo/farmacología , Proteínas/fisiología , ARN Mensajero/metabolismo , Selenio/metabolismo , Selenoproteínas , Transfección , Células Tumorales CultivadasRESUMEN
Mammalian selenium-containing proteins can be divided into three groups: proteins containing nonspecifically incorporated selenium, specific selenium-binding proteins, and specific selenocysteine-containing selenoproteins. Selenoproteins with known functions identified so far include five glutathione peroxidases, two deiodinases, several thioredoxin reductases, and selenophosphate synthetase 2. Alternative splicing leads to a greater variety of selenoproteins, as was shown in the cases of a specific sperm nuclei glutathione peroxidase and some thioredoxin reductases. Selenoprotein P, selenoprotein W, a 15-kDa selenoprotein, an 18-kDa selenoprotein, and several selenoproteins identified in silico from nucleotide sequence databases were found to contain selenocysteine but their functions are not known. Gel electrophoretic separation of tissue samples from rats labeled in vivo with (75)Se showed the existence of further selenium-containing proteins.
Asunto(s)
Proteínas/química , Selenio/análisis , Animales , Proteínas Portadoras , Glutatión Peroxidasa/fisiología , Humanos , Yoduro Peroxidasa/fisiología , Proteínas/fisiología , Proteínas de Unión al Selenio , Selenoproteína P , Selenoproteína W , Selenoproteínas , Reductasa de Tiorredoxina-Disulfuro/fisiologíaRESUMEN
During the metamorphosis of the Xenopus laevis retina, thyroid hormone (TH) preferentially induces ventral ciliary marginal zone (CMZ) cells to both increase their proliferation and give rise to ipsilaterally projecting ganglion cells. Here we show that dorsal CMZ cells express type III deiodinase (D3), an enzyme that inactivates TH. The dorsal CMZ cells can be induced to proliferate if deiodinase activity is inhibited. D3 or dominant-negative thyroid hormone receptor transgenes inhibit both TH-induced proliferation of the ventral CMZ cells and the formation of the ipsilateral projection. Thus, the localized expression of D3 in the dorsal CMZ cells accounts for the asymmetric growth of the frog retina.
Asunto(s)
Yoduro Peroxidasa/fisiología , Metamorfosis Biológica/fisiología , Retina/enzimología , Retina/crecimiento & desarrollo , Animales , Antimetabolitos , Bromodesoxiuridina , Medios de Contraste/farmacología , Inhibidores Enzimáticos/farmacología , Hibridación in Situ , Yoduro Peroxidasa/antagonistas & inhibidores , Ácido Yopanoico/farmacología , ARN Mensajero/biosíntesis , Tálamo/citología , Tálamo/crecimiento & desarrollo , Tálamo/fisiología , Vías Visuales/citología , Vías Visuales/crecimiento & desarrollo , Vías Visuales/fisiología , Xenopus laevisRESUMEN
The realization some forty years ago that several iodothyronine compounds are present in the circulation suggested that deiodination occurs in various tissues. Subsequently, deiodination was indeed documented in in vivo studies. Later, using in vitro assay techniques, three deiodinase processes, termed types 1, 2 and 3, were defined that differed in terms of tissue distribution, reaction kinetics, efficiency of substrate utilization and sensitivity to inhibitors. Although purification of the deiodinase enzymes has continued to be problematic, recent molecular cloning studies have identified cDNAs for these three deiodinase isoforms from multiple species. These cDNAs have provided important insights into the structural characteristics of this family of enzymes. Foremost among the structural features has been the demonstration that all three deiodinase isoforms contain at their active site the uncommon amino acid selenocysteine which is of critical importance to their catalytic activity. The availability of cDNAs for these enzymes provides important reagents for pursuing additional studies aimed at defining their biochemical features and roles in thyroid hormone economy.
Asunto(s)
Yoduro Peroxidasa , Proteínas , Animales , Clonación Molecular , Crecimiento , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Yoduro Peroxidasa/genética , Yoduro Peroxidasa/historia , Yoduro Peroxidasa/metabolismo , Yoduro Peroxidasa/fisiología , Selenio , Selenoproteínas , Hormonas Tiroideas/historia , Hormonas Tiroideas/metabolismoRESUMEN
Within a case-control study of postmenopausal breast cancer patients (n = 99) and matched healthy controls (n = 105), thyroid hormone levels were compared and correlated with toenail selenium concentrations. Plasma triiodothyronine (T3) was significantly lower in cases (1.4 +/- 0.4 nmol/l) than in controls (1.6 +/- 0.4 nmol/l), and a strong inverse relationship with breast cancer was observed with an odds ratio of 0.17 (95% CI = 0.08-0.36) in the highest compared with the lowest tertile of T3. Plasma thyroxine and thyroid-stimulating hormone concentrations were similar between cases and controls. Plasma T3 concentration was positively associated with toenail selenium in cases (age-adjusted regression coefficient = 0.049) and controls (age-adjusted regression coefficient = 0.036). Toenail selenium concentrations tended to be lower in cases than in controls, but the differences did not reach statistical significance. Although the disease process per se may explain the lower plasma T3 concentrations, it is also possible, inasmuch as these patients were in early-stage breast cancer, that selenium status may be influencing T3 levels via changes in the activity of the selenoenzyme type 1 iodothyronine deiodinase.
Asunto(s)
Neoplasias de la Mama/metabolismo , Selenio/análisis , Hormonas Tiroideas/sangre , Anciano , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/etiología , Estudios de Casos y Controles , Femenino , Humanos , Yoduro Peroxidasa/fisiología , Persona de Mediana Edad , Uñas/química , Irlanda del Norte/epidemiología , Análisis de Regresión , Factores de Riesgo , Selenio/metabolismo , Selenio/fisiología , Tirotropina/sangre , Tiroxina/sangre , Dedos del Pie , Triyodotironina/sangreRESUMEN
Development and tissue-specific deiodination of thyroid hormone leads to both activation of the prohormone thyroxine to the thyromimetically active T3 as well as to inactivation of T3 and its conjugates or inactivation of T4 to yield potential regulatory active rT3. At least three deiodinase isoenzymes have so far been characterized and cloned, and the deiodinase isozymes represent a new family of eukaryotic selenoproteins for which an enzyme function could be assigned. Selenium status apparently regulates the expression of these deiodinase isozymes to different extent indicating that a hierarchy of selenium incorporation exists for those enzymes. Currently, it appears that selenium deficiency does not affect expression of type II 5'-deiodinase or 5-deiodinase to a marked extent in vivo whereas type I 5'-deiodinase at least in liver and kidney is reduced in severe selenium deficiency. However, daily selenium intake in normal mideuropeans already saturates the requirement for the expression of the deiodinase isoenzymes. So far, only reduced expression of 5'-D I and decreased T 3 production has been observed in specific diets such as for PKU or in cystic fibrosis, where transport of ions (iodide, selenite?) might be affected. Further alterations of T3 production by 5'-D I activity are observed under the conditions of the low T3 syndrome, which comprise a broad spectrum of clinical disorders from carbohydrate withdrawal to intensive care patients. It is not yet clear if selenium supplementation or T3 treatment is beneficial to these patients. The marked tissue-specificity of expression of the deiodinases requires more detailed examinations on the relation between these enzymes and the expression of thyroid hormone action, which is mediated by the nuclear T3 receptor family or receptors and signal transduction molecules in the mitochondria, plasma membrane, or cytoskeleton. The location of the deiodinase enzymes either at the inner side of the plasma membrane or the cytosolic side of the endoplasmic reticulum positions these enzymes to a strategically important location enabling them to act as gate-keepers to the nuclear receptors. Similar to other enzymes involved in the activation or inactivation of compounds with hormone or signalling function, the deiodinases are key elements in the intracrine regulation of hormone activation in target tissues or inactivation in non-target tissues. Therefore, a detailed molecular, cell biological and physiological analysis of the function, regulation and gene structure of these enzymes is required before a development of tissue- or enzyme-specific pharmacological intervention is possible. Nevertheless, first data indicate that reduced 5'-deiodinase type I expression in tumor tissues can be re-induced by treatment with retinoids at least in follicular thyroid carcinoma. Further studies are needed to prove that retinoids might be a useful therapeutic tool for re-differentiation therapy of thyroid carcinoma which are inaccessible to surgical intervention or lack radio-iodide uptake and storage. The important function and regio- and cell-specific expression of deiodinase isozymes in the central nervous system is far from being understood. Current first evidence suggests a close interaction between thyroid hormone deiodination, thyroid hormone concentration, and expression of thyroid hormone responsive genes in the adult brain as well as tight regulation and interaction between thyroid hormone metabolism and neurotransmitter synthesis release and action.
Asunto(s)
Yoduro Peroxidasa/fisiología , Selenio/fisiología , Hormonas Tiroideas/metabolismo , Animales , Encéfalo/enzimología , Homeostasis/fisiología , Humanos , Isoenzimas/fisiología , Riñón/enzimología , Hígado/enzimología , Hipófisis/enzimología , Placenta/enzimología , Proteínas/fisiología , Selenoproteínas , Distribución TisularRESUMEN
In guinea pigs, activity of glutathione peroxidase in most organs is markedly lower than in organs of other rodents despite comparable dietary intakes and tissue levels of selenium. To determine if metabolism of selenium with respect to other selenoproteins also differs in guinea pigs, we measured the effects of selenium intake on thyroid hormone metabolism. Weanling male Hartley Albino guinea pigs were fed a selenium-deficient Torula yeast-based diet, or the same diet supplemented with 0.5 mg selenium/kg diet as sodium selenate for 72 d. Growth was impaired in guinea pigs fed the unsupplemented diet. Activity of glutathione peroxidase was higher in tissues and plasma of supplemented guinea pigs than in selenium-deficient animals. However, it was still far lower than reported values for other rodent species. In selenium deficiency, activity of type 1 5'-iodothyronine deiodinase was 60% less in liver and 45% less in kidney. Concentration of thyroxine was 68% lower in kidney of selenium-deficient animals, and levels of 3,3',5-triiodothyronine in kidney and plasma were 44 and 31% lower, respectively. Thus, with the exception of thyroxine concentrations, thyroid hormone metabolism responds to selenium deficiency in guinea pigs as it does in rats, although the magnitude of that response is not as great.
Asunto(s)
Selenio/deficiencia , Hormonas Tiroideas/metabolismo , Animales , Glutatión Peroxidasa/análisis , Glutatión Peroxidasa/metabolismo , Glutatión Peroxidasa/fisiología , Crecimiento/efectos de los fármacos , Crecimiento/fisiología , Cobayas , Yoduro Peroxidasa/análisis , Yoduro Peroxidasa/metabolismo , Yoduro Peroxidasa/fisiología , Riñón/química , Riñón/enzimología , Riñón/fisiología , Hígado/química , Hígado/enzimología , Hígado/fisiología , Masculino , Selenio/fisiología , Hormonas Tiroideas/análisis , Hormonas Tiroideas/sangre , Tiroxina/análisis , Tiroxina/sangre , Tiroxina/metabolismo , Triyodotironina/análisis , Triyodotironina/sangre , Triyodotironina/metabolismoRESUMEN
Selenocysteine has been identified in the active center of types 1 and 3 iodothyronine deiodinases, two important enzymes regulating the formation and degradation of the active thyroid hormone, 3,5,3'-triiodothyronine (T3). Selenium is thus required for such complex processes as normal growth, brain development, and metamorphosis, all of which are thyroid hormone dependent. Structural and functional analyses of the type 1 deiodinase mRNA allowed identification of the selenocysteine insertion sequence (SECIS) element, a stem-loop structure in the 3' untranslated region of the mRNA. SECIS elements with conserved sequence and structural features are also present in the 3' untranslated regions of the mRNAs encoding selenoprotein P and the glutathione peroxidase family of selenoproteins. These elements are necessary and sufficient for directing selenocysteine incorporation into the deiodinases and the other mammalian selenoproteins.
Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales , Yoduro Peroxidasa/fisiología , Glándula Tiroides/fisiología , Secuencia de Aminoácidos , Animales , Perros , Humanos , Yoduro Peroxidasa/antagonistas & inhibidores , Yoduro Peroxidasa/química , Datos de Secuencia Molecular , Ratas , Selenio/deficiencia , Selenio/metabolismo , Glándula Tiroides/enzimología , Tiroxina/metabolismo , Tiroxina/fisiología , Triyodotironina/metabolismo , Triyodotironina/fisiologíaRESUMEN
The possible influence of hypothalamic and pituitary 5'-deiodinase II (5'-D-II) activity and 3,5,3'-triiodothyronine (T3) content on the modulation of thyroid-stimulating hormone (TSH) synthesis was studied. 1) Alterations in 5'-D-II activity and hypothalamic and pituitary T3 content produced by undernutrition were observed in fetal (21 days) and neonatal rats vs. controls. 2) After thyroidectomy, plasma TSH increased in both populations, undernourished and control, but pituitary TSH increased only in the former and not in the latter. The results obtained by giving small doses of thyroxine (T4; 0.5 micrograms/100 g body wt) to intact and thyroidectomized rats suggest a lower inhibitory effect by T4 on the pituitary in undernourished than in control rats. Although hypothalamic and pituitary 5'-D-II activity increased in both groups after thyroidectomy, the percentage increase was lower in undernourished vs. control rats, resulting in lower overall T3 content in tissues from undernourished animals. These studies on thyroid axis regulation show the in vivo regulation of TSH synthesis by hypothalamic and pituitary 5'-D-II activity and T3 content.
Asunto(s)
Hipotálamo/metabolismo , Yoduro Peroxidasa/fisiología , Trastornos Nutricionales/metabolismo , Hipófisis/metabolismo , Hormonas Tiroideas/metabolismo , Tirotropina/metabolismo , Animales , Femenino , Masculino , Ratas , Ratas Wistar , Hormonas Tiroideas/análisis , TiroidectomíaRESUMEN
Two types of iodothyronine deiodinase (ID-I and ID-II) catalyse the 5'-deiodination of thyroxine (T4) to produce the biologically active triiodothyronine (T3). Under normal circumstances ID-I in liver and kidney provides the main source of T3 to the circulation, whilst ID-II is largely responsible for local T3 production in the CNS, brown adipose tissue and pituitary. In some circumstances ID-II in brown adipose tissue and ID-I in the thyroid may provide a significant source of plasma T3, and ID-I in the pituitary may be important for local T3 production in this gland. The IDs thus play a pivotal role in controlling the supply of T3 to the nuclear receptors. ID-I is a selenoenzyme and, although ID-II activity is reduced in selenium deficiency, this is a consequence of increased plasma T4 concentration, rather than ID-II activity being directly dependent on selenium. Changes in 5'-deiodination occur in a number of situations such as poor nutrition, illness, iodine and selenium deficiency, and drug therapy. In iodine deficiency these changes appear to have evolved to ensure that the plasma T3 level is maintained and also to provide the brain with a degree of protection from hypothyroxinaemia. Relatively little is known about the importance of selenium deficiency on thyroid function in humans but, in combination with iodine deficiency, selenium deficiency may prove to be a contributing factor in the pathogenesis of myxodematous cretinism. The changes that occur in ID-I and ID-II in illness produce abnormalities in thyroid function tests which, although of no direct clinical significance, may lead to interpretative problems.